Philips introduces industry-first cath lab integration that automatically synchronizes pre-operative CT with C-arm movement, paving the way for CT-guided PCI
Royal Philips (NYSE:PHG) announced at TCT 2025 an industry-first integration that links pre-operative CT (AVW) with the Azurion image-guided therapy platform to automatically synchronize CT 3D reconstructions with C-arm movement. The feature, called Follow C-arm, rotates the CT volume in real time to match C-arm angulation, aiming to combine CCTA anatomical detail with live X-ray guidance and support a shift toward CT-guided PCI.
The release notes prior publications associating CCTA use with reduced contrast and radiation, and reiterates Azurion’s global footprint of more than 6.4 million patients treated annually in 80+ countries.
Royal Philips (NYSE:PHG) ha annunciato al TCT 2025 una integrazione líder nell'industria che collega la TAC preoperatoria (AVW) alla piattaforma di terapia guidata da immagini Azurion per sincronizzare automaticamente le ricostruzioni 3D della TAC con il movimento dell'angolazione del C-arm. La funzione, chiamata Follow C-arm, ruota in tempo reale il volume TAC per allinearsi all'angolazione del C-arm, con l'obiettivo di combinare i dettagli anatomici della CCTA con la guida X-ray in tempo reale e supportare lo spostamento verso la PCI guidata da TAC. Le note di rilascio richiamano precedenti pubblicazioni che associano l'uso della CCTA a una riduzione di contrasto e radiazioni, e ribadiscono l’impronta globale di Azurion di oltre 6,4 milioni di pazienti trattati ogni anno in oltre 80 paesi.
Royal Philips (NYSE:PHG) anunció en TCT 2025 una integración pionera en la industria que vincula la TC preoperatoria (AVW) con la plataforma de terapia guiada por imágenes Azurion para sincronizar automáticamente las reconstrucciones 3D de TC con el movimiento del C-arm. La función, llamada Follow C-arm, rota el volumen de TC en tiempo real para coincidir con la angulación del C-arm, con el objetivo de combinar el detalle anatómico de la CCTA con la guía por rayos X en vivo y apoyar un cambio hacia PCI guiada por TC. Las notas de la versión recogen publicaciones previas que asocian el uso de la CCTA con una reducción de contraste y radiación, y reitera la huella global de Azurion de más de 6,4 millones de pacientes tratados anualmente en más de 80 países.
로열 필립스(NYSE:PHG)는 TCT 2025에서 업계 최초의 통합을 발표했습니다. 이 통합은 수술 전 CT(AVW)를 Azurion 영상 가이드 치료 플랫폼에 연결하여 CT 3D 재구성을 C-암(C-arm) 동작과 자동으로 동기화합니다. 이 기능은 Follow C-arm이라 불리며, C-arm 각도와 일치하도록 CT 볼륨을 실시간으로 회전시켜 CCTA 해부학적 디테일과 실시간 X-선 가이드를 결합하고 CT 가이드 PCI로의 전환을 지원하는 것을 목표로 합니다. 릴리스 노트는 CCTA 사용과 조영제 및 방사선 감소를 연관 짓는 이전 발표를 언급하고, Azurion의 전 세계 입지를 80개국 이상에서 매년 640만 명이 치료받고 있음을 재확인합니다.
Royal Philips (NYSE:PHG) a annoncé lors du TCT 2025 une intégration exclusive qui relie la TDM préopératoire (AVW) à la plateforme de thérapie guidée par l’image Azurion pour synchroniser automatiquement les reconstructions 3D de la TDM avec le mouvement du bras C. La fonctionnalité, appelée Follow C-arm, fait pivoter le volume CT en temps réel pour correspondre à l’angle du bras C, dans le but de combiner le détail anatomique de la CCTA avec une guidage fluoroscopique en direct et de soutenir une transition vers la PCI guidée par CT. Les notes de version font référence à des publications antérieures liant l’utilisation de la CCTA à une réduction du contraste et des radiations, et réitèrent l’emprise mondiale d’Azurion de plus de 6,4 millions de patients traités annuellement dans plus de 80 pays.
Royal Philips (NYSE:PHG) kündigte auf der TCT 2025 eine branchenweit erste Integration an, die die präoperative CT-Aufnahme (AVW) mit der Azurion-Bildgebungstherapie-Plattform verbindet, um CT-3D-Rekonstruktionen automatisch mit dem C-Arm-Winkel zu synchronisieren. Die Funktion namens Follow C-arm rotiert das CT-Volumen in Echtzeit, um sich dem C-Arm-Winkel anzupassen, mit dem Ziel, die anatomischen Details der CCTA mit Live-Röntgenführung zu kombinieren und eine Verschiebung hin zu CT-gesteuerter PCI zu unterstützen. Die Release-Notes verweisen auf frühere Publikationen, die die Verwendung der CCTA mit reduziertem Kontrastmittel- und Strahlungsdosis in Verbindung bringen, und bekräftigen Azurions globale Präsenz mit mehr als 6,4 Millionen jährlich behandelten Patienten in über 80 Ländern.
Royal Philips (NYSE:PHG) أعلنت في TCT 2025 عن تكامل رائد في الصناعة يربط التصوير بالرنين المحوري قبل الجراحة (AVW) بمنصة Azurion للعلاج الموجه بالصورة ليتزامن تلقائياً مع حركة ذراع C-Arm ثلاثي الأبعاد. الميزة المسماة Follow C-arm تقوم بتدوير حجم CT في الوقت الفعلي ليتطابق مع زاوية C-arm، بهدف الجمع بين التفاصيل التشريحية لـ CCTA مع التوجيه بالأشعة السينية الحية ودعم التحول نحو PCI الموجهة بـ CT. تذكر ملاحظات الإصدار منشورات سابقة تربط استخدام CCTA بانخفاض التباين والإشعاع، وتعيد تأكيد وجود Azurion عالمياً بواقع أكثر من 6.4 مليون مريض يتم علاجهم سنوياً في أكثر من 80 دولة.
Royal Philips (NYSE:PHG)在 TCT 2025 上宣布了一项行业首创的集成，将术前 CT（AVW）与 Azurion 图像引导治疗平台连接，以实现 CT 3D 重建与 C 臂运动的自动同步。该功能名为 Follow C-arm，可实时旋转 CT 体积以匹配 C-Arm 的仰角，旨在将 CCTA 的解剖细节与实时 X 射线引导相结合，并支持向 CT 引导的 PCI 转变。发布说明回顾了先前的出版物，将 CCTA 的使用与对比剂和辐射减少相关联，并重申 Azurion 在全球的覆盖范围：每年在 80 多个国家治疗的患者超过 640 万名。
- Automated CT–C-arm synchronization for real-time 3D alignment
- Supports CT-guided PCI workflow by combining CT and live X-ray
- Azurion used to treat >6.4M patients annually in 80+ countries
- None.
Insights
Philips links pre-op CT to C-arm motion, enabling CT-guided PCI workflows and aiming to reduce contrast and radiation in complex procedures.
Philips introduces an integration of the Advanced Visualization Workspace with the Azurion platform that automatically synchronizes a 3D CT reconstruction with C-arm angulation in real time. This changes the procedural mechanics by removing manual registration steps and delivering a continuously aligned anatomical overlay during PCI, which can speed decision-making and preserve the operator’s fluoroscopic workflow.
The practical impact depends on image registration accuracy, latency under clinical conditions, and compatibility with existing pre-operative CT protocols and PACS. The press text cites potential reductions in contrast medium use and radiation dose based on publications, but it does not provide validation data, CE/510(k) details, or performance metrics under live-case variability; those items are critical to assess clinical benefit and adoption speed.
Watch for published validation studies, regulatory clearances, and real-world performance reports over the next
October 27, 2025
New integration of Philips Advanced Visualization Workspace* with the Azurion image-guided therapy platform automatically synchronizes CT images with C-arm movement, supporting workflow efficiency and additional anatomical insights in PCI procedures1
San Francisco, USA and Amsterdam, The Netherlands – At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today introduced an industry-first innovation that integrates pre-operative CT data directly into the cath lab workflow. This new capability, available through the integration of Philips’ Advanced Visualization Workspace (AVW) with the Azurion image-guided therapy system, marks a first step towards CT-guided percutaneous coronary intervention (PCI), a minimally invasive procedure to open narrowed coronary arteries and restore blood flow to the heart.
The new capability, Follow C-arm, automatically synchronizes the 3D reconstruction of coronary arteries with the movement of the Azurion C-arm. As the C-arm angulation changes, the CT volume rotates in real time to match, giving interventionalists the 3D anatomical view without manual interaction. This seamless connection helps clinicians combine the detailed insights of CT imaging with the flexibility of live X-ray guidance inside the cath lab. The combined AVW–Azurion approach aims to provide enhanced anatomical insights to guide complex PCI procedures, publications have shown that leveraging CCTA may lead to reduction in contrast medium use and radiation dose during interventions.1
Supporting the shift towards CT-guided PCI
Coronary computed tomography angiography (CCTA) is increasingly used in global clinical guidelines as a first-line tool for the diagnosis and planning of coronary artery disease. With more patients now arriving at the cath lab with prior CT scans, physicians are seeking ways to incorporate this information into their interventional workflows. By integrating CT data directly into Azurion, Philips is helping interventionalists expand the use of CT beyond diagnosis and planning, supporting a future in which CT-guided PCI becomes standard practice.
“By bringing pre-operative CT into the cath lab and linking it directly to the movement of the C-arm, Philips is delivering an industry-first that helps interventionalists prepare for and execute PCI procedures with greater confidence,” said Mark Stoffels, Business Leader Image-Guided Therapy Systems at Philips. “This seamless integration is a significant step towards CT-guided PCI, aligning with our commitment to improving workflow efficiency and advancing patient care in interventional cardiology.”
The launch builds on the global success of Philips’ Azurion image-guided therapy platform, the world’s leading system designed for seamless integration of advanced applications. Since its introduction in 2017, Azurion has been used to treat more than 6.4 million patients annually in over 80 countries, helping physicians perform minimally invasive procedures with greater confidence and efficiency.
For more information about Philips’ presence at TCT, please visit the Philips TCT 2025 landing page.
For further information, please contact:
Joost Maltha
Philips Global External Relations
Tel.: +31 6 1055816
E-mail: joost.maltha@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,800 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Disclaimer: * The Follow C-arm capability as part of Philips Advanced Visualization Workspace may not be available in all markets. Please contact your Philips representative for more details.
Reference: 1. J Cardiovasc Comput Tomogr. 2025 May-Jun;19(3):277-290.
Attachments
FAQ
What did Philips (PHG) announce at TCT 2025 about CT and Azurion integration?
How does the Follow C-arm feature affect PCI procedures for PHG Azurion users?
Does Philips claim Follow C-arm reduces contrast medium or radiation for PHG procedures?
When and where was Philips’ CT–C-arm integration announced for PHG investors?
What is Azurion’s clinical footprint cited in the PHG announcement?
Will the new Philips PHG integration make CT-guided PCI standard practice immediately?
